The world market for enzyme coupled immunosorbent assays (ELISA) is projected to expand as a result of increased product development work for ELISA kits. For illustration, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance was created on May 21, 2021, by the Defence Institute of Physiology and Allied Sciences (DIPAS), a lab of the Defence Research and Development Organization (DRDO), India. The DIPCOVAN kit has a high sensitivity of 97% and a specificity of 99% for the detection of both the spikes and nucleocapsid proteins of the SARS-CoV-2 virus. The diagnosis design and construction company Vanguard Diagnostics Pvt Ltd had collaborated on the development of the kit.
Global Enzyme Linked Immunosorbent Assay (ELISA) Market is estimated to be valued at US$ 2,016.1 million in 2022 and is expected to exhibit a CAGR of 5.1% during the forecast period (2022-2030).
Leading Companies in the Enzyme Linked Immunosorbent Assay (ELISA) Industry:
1. Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. In September, 2019 Bio-Rad Laboratories, Inc. announced the launch of the Science of Opioid Dependence Kit, offering high school and undergraduate educators a simple hands-on DNA electrophoresis activity to teach complex genetics in the context of the opioid crisis.
2. Enzo Life Sciences, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences Company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is headquartered in Farmingdale, New York. Enzo Biochem, Inc announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York.